Abstract
Calcium plays a major role in a wide range of cellular functions. In the extracellular fluid matrix, calcium is present in millimolar concentrations, whereas free intracellular calcium is up to 10,000 times less plentiful. This compartmentalization is accomplished by (1) limited permeability of the resting plasma membrane to calcium, (2) cellular mechanisms for calcium extrusion, (3) buffering within the cytosol, and (4) sequestration of calcium into intracellular organelles.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Greenburg, D. A., 1987, Calcium channels and calcium channel antagonists, Ann. Neurol 21:317–330.
Hagiwara, S., and Byerly, L., 1981, Membrane biophysics of calcium currents, Fed. Proc 40:2220–2225.
Hille, B., 1984, Elementary properties of ions in solution, in: Ionic Channels of Excitable Membranes, Sinauer Associates, Sunderland, MA, pp. 249–271.
Hille, B., 1984, Selective permeability: Saturation and binding, in: Ionic Channels of Excitable Membranes, Sinauer Associates, Sunderland, MA, pp. 272–291.
Triggle, D. J., 1982, Biochemical pharmacology of calcium blockers, in: Calcium Blockers, Mechanisms of Action and Clinical Applications( S. F. Flaim and R. Zelis, eds.), Urban & Schwarzenberg, Baltimore, Munich, pp. 121–134.
Tsien, R. W., Hess, P., McClesky, E. W., and Rosenberg, R. L., 1987, Calcium channels: Mechanisms of selectivity, permeation, and block, Annu. Rev. Biophys. Biophys. Chem 16:265– 290.
McClesky, E. W., and Aimers, W., 1985, The Ca channel in skeletal muscle is a large pore, Proc. Natl. Acad. Sci. U.S.A 82:7149–7153.
McClesky, E. W., Hess, P., and Tsien, R. W., 1985, Interaction of organic cations with the cardiac Ca channel, J. Gen. Physiol 86:22a.
Hille, B., 1973, Potassium channels in mylenated neurons. Selective permeability to small cations, J. Gen. Physiol 61:669–686.
Coronado, R., and Miller, C., 1982, Conduction and block by organic cations in a K + -selective channel from sarcoplasmic reticulum incorporated into planar phospholipid bilayers, J. Gen. Physiol 79:529–547.
Jmari, K., Mironneau, C., and Mironneau, J., 1987, Selectivity of calcium channels in rat uterine smooth muscle: Interactions between sodium, calcium and barium ions, J. Physiol. (Lond.) 384:247–261.
Mironneau, J., Eugene, D., and Mironneau, C., 1982, Sodium action potentials induced by calcium chelation in rat uterine smooth muscle, Pflugers Arch 352:197–210.
Prosser, C. L., Kreulen, D. L., Weigel, R. J., and Yau, W., 1977, Prolonged action potentials in gastrointestinal muscles induced by calcium chelation, Am. J. Physiol 233:C19–C24.
Potreau, D., and Raymond, G., 1982, Existence of a sodium-induced calcium release mechanism on frog skeletal muscle fibers, J. Physiol. (Lond.) 333:463–480.
Miller, D. J., 1979, Are cardiac cells “skinned” by EGTA or EDTA? Nature 277:142–143.
Kaas, R. S., and Scheuer, T., 1982, Calcium ions and cardiac electrophysiology, in: Calcium Blockers: Mechanisms of Action and Clinical Applications( S. F. Flaim and R. Zelis, eds.), Urban & Schwarzenberg, Baltimore, pp. 3–19.
Beeler, G. W., and Reuter, H., 1970, Membrane calcium current in ventricular myocardial fibers, J. Physiol. (Lond.) 207:191–209.
Hurwitz, L., 1986, Pharmacology of calcium channels and smooth muscle, Annu. Rev. Phar¬macol. Toxicol 26:225–258.
Reuter, H., 1983, Calcium channel modulation by neurotransmitters, enzymes and drugs, Nature 301:569–574.
Hille, B., 1984, Counting channels, in: Ionic Channels of Excitable Membranes, Sinauer Associates, Sunderland, MA, pp. 205–225.
Rimele, T. J., and Vanhoutte, P. M., 1984, Differential effects of calcium entry blockers on vascular smooth muscle, Int. Angiol 3:17–23.
Bolton, T. B., 1979, Mechanisms of action of transmitter and other substances on smooth muscle, Physiol. Rev 59:606–718.
Meisheri, K. D., Hwang, O., and Van Breemen, C., 1981, Evidence for two separate Ca2+ pathways in smooth muscle plasmalemma, J. Membr. Biol 59:19–25.
Van Breemen, C., Aaronson, P. I., Cauvin, C. A., Loutzenhiser, R. D., Mangel, A. W., and Saida, K., 1982, The calcium cycle in arterial smooth muscle, in: Calcium Blockers: Mechanisms of Action and Clinical Applications( S. F. Flaim and R. Zelis, eds.), Urban & Schwarzenberg, Baltimore, pp. 53–63.
Chiu, A. T., McCall, D. E., and Timmermans, P. B. M., 1986, Pharmacological characterization of receptor–operated and potential-operated Ca2+ channels in rat aorta, Eur. J. Pharmacol 127:1– 8.
Ratz, P. H., and Flaim, S. F., 1985, Acetylcholine- and 5-hydroxtryptamine-stimulated contraction and calcium uptake in bovine coronary arteries: Evidence for two populations of receptor– operated calcium channels, J. Pharmacol. Exp. Ther 234:641–647.
Benham, C. D., and Tsien, R. W., 1987, A novel receptor–operated Ca2 + -permeable channel activated by ATP in smooth muscle, Nature 328:275–278.
Sakai, K., Yamaguchi, T., Morita, S., and Uchida, M., 1983, Agonist–induced contraction of rat myometrium in Ca2+ -free solution containing Mn, Gen. Pharmacol 14:391–400.
Inomata, H., and Kao, C. Y., 1976, Ionic currents in the guinea-pig taenia coli, J. Physiol. (Lond.) 255:347–378.
Hagiwara, S., and Ohmori, H., 1982, Studies of Ca channels in rat clonal pituitary cells with patch electrode voltage clamp, J. Physiol. (Lond.) 331:599–635.
Brown, A. M., Morimoto, K., Tsuda, Y., and Wilson, D. L., 1981, Calcium current-dependent and voltage-dependent inactivation of calcium channels in Helix aspersa, J. Physiol. (Lond.) 320:193–218.
Hille, B., 1984, Calcium channels, in: Ionic Channels of Excitable Membranes, Sinauer Associates, Sunderland, MA, pp. 76–98.
Fukushima, Y., and Hagiwara, S., 1983, Voltage-gated Ca2+ channel in mouse myeloma cells, Proc. Natl. Acad. Sci. U.S.A 80:2240–2242.
Fox, A. P., 1981, Voltage-dependent inactivation of a calcium channel, Proc. Natl. Acad. Sci. U.S.A 78:953–956.
Eckert, R., and Chad, J. E., 1984, Inactivation of channels, Prog. Biophys, Mol. Biol 44:215– 267.
Chad, J., Eckert, R., and Ewald, D., 1984, Kinetics of calcium dependent inactivation of calcium current in voltage clamped neurons of Aplysia californica, J. Physiol. (Lond.) 347:279–300.
Eckert, R., and Tillotoson, D., 1981, Calcium mediated inactivation of the calcium conductance in calcium loaded giant neurons of Aplysia californica, J. Physiol. (Lond.) 314:265–280.
Jmari, K., Mironneau, C., and Mironneau, J., 1986, Inactivation of calcium channel current in rat uterine muscle: Evidence for calcium- and voltage-mediated mechanisms, J. Physiol. (Lond.) 380:111–126.
Llinas, R., Steinberg, I. Z., and Walton, K., 1981, Presynaptic calcium currents in squid giant synapse, Biophys. J 33:289–322.
Worley, J. F., Deitmer, J. W., and Nelson, M. T., 1986, Single nisoldipine-sensitive calcium channels in smooth muscle cells isolated from rabbit mesenteric artery, Proc. Natl. Acad. Sci. U.S.A 83:5746–5750.
Sturek, M., and Hermsmeyer, K., 1986, Calcium and sodium channels in spontaneously contracting vascular muscle cells, Science 233:475–478.
Bean, B. P., 1985, Two kinds of calcium channels in canine atrial cells, J. Gen. Physiol 86:1–30.
Mitra, R., and Morad, M., 1986, Two types of calcium channels in guinea pig ventricular myocytes, Proc. Natl. Acad. Sci. U.S.A 83:5340–5344.
Cognard, C., Lazdunski, M., and Romey, G., 1986, Different types of Ca2+ channels in mammalian skeletal muscle cells in culture, Proc. Natl. Acad. Sci. U.S.A 83:517–521.
Nowycky, M. C., Fox, A. P., and Tsien, R. W., 1985, Three types of neuronal calcium channels with different calcium agonist sensitivity, Nature 316:440–443.
Carbone, E., and Lux, H. D., 1984, A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurons, Nature 310:501–502.
Armstrong, C. M., and Matteson, D. R., 1985, Two distinct populations of calcium channels in a clonal line of pituitary cells, Science 227:65–67.
Hess, P., Lansman, J. B., and Tsien, R. W., 1986, Calcium channel selectivity for monovalent and divalent cations, J. Gen. Physiol 88:293–319.
Lansman, J. B., Hess, P., and Tsien, R. W., 1986, Blockade of current through single calcium channels by Cd2+, Mg2+, and Ca2+, J. Gen. Physiol 88:321–347.
Godfraind, T., 1986, Calcium antagonism and calcium entry blockade, Pharmacol. Rev 38:321– 416.
Kuriyama, H., and Suzuki, H., 1976, Effects of prostaglandin E2 and oxytocin on the electrical activity of hormone-treated and pregnant rat myometria, J. Physiol (Lond.) 260:335–349.
Reiner, O., and Marshall, J. M., 1976, Action of PGF2α on the uterus of the rat, Arch. Pharmacol 292:243–250.
Carsten, M. E., 1974, Prostaglandins and oxytocin: Their effects on uterine smooth muscle, Prostaglandins 5:33–40.
Levitan, I., 1985, Phosphorylation of ion channels, J. Membr. Biol 87:177–190.
Ousterhout, J. M., and Sperelakis, N., 1985, Role of cyclic nucleotides in regulation of slow channel function in vascular smooth muscle, Biophys. J 47:266a.
Godfraind, T., 1986, EDRF and cyclic GMP control gating of receptor operated calcium channels in vascular smooth muscle, Eur. J. Pharmacol 126:341–343.
Richards, I. S., Ousterhout, J. M., Sperelakis, N., and Murlas, C. G., 1987, cAMP suppresses Ca2+-dependent electrical activity of airway smooth muscle induced by TEA, J. Appl. Physiol 62:175–179
Richards, I. S., Murlas, C., Ousterhout, J. M., and Sperelakis, N., 1987, 8-Bromo-cyclic GMP abolishes TEA-induced slow action potentials in canine tracheal muscle, Eur. J. Pharmacol 128:299–302
Brown, A. M., and Birnbaumer, L., 1988, Direct G protein gating of ion channels, Am. J. Physiol 254:H401–H410.
Irvine, R. F., 1987, Inositol phosphate and calcium entry, Nature 328:386.
Godfraind, T., 1986, Calcium entry blockade and excitation contraction coupling in the cardiovascular system, Acta Pharmacol. Toxicol 58(Suppl. 2): 5–30.
van Proosdij-Hartzema, E. G., and de Jongh, D. K., 1959, A new piperazine compound with antihistaminic activity, Acta Physiol. Pharmacol. Neerl 8:337–342.
Fleckenstein, A., 1964, Die Bedeutung der energiereichen Phosphate fur Kontraktilitat und Tonus des Myokards, Verh. Dtsch. Ges. Inn. Med 70:81–99.
Godfraind, T., Kaba, A., and Polster, P., 1968, Differences in sensitivity of arterial smooth muscles to inhibition of their contractile response to depolarization by potassium, Arch. Int. Pharmacodyn. Ther 172:235–239.
Spedding, M., 1985, Calcium antagonist subgroups, Trends Pharmacol. Sci 6:109–114.
Janis, R. A., and Triggle, D. J., 1983, New developments in Ca2+ channel antagonists, J. Med. Chem 26:775–785.
Godfraind, T., and Kaba, B., 1969, Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle, Br. J. Pharmacol 35:549–560.
Bolger, G. T., Gengo, P., Klockowski, R., Luchowski, E., Siegel, H., Janis, R. A., Triggle, A. M., and Triggle, D. J., 1983, Characterization of binding of the Ca2+ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle, J. Pharmacol. Exp. Ther 225:291–309.
Grover, A. K., Kwan, C.-Y., Luchowski, E., Daniel, E. E., and Triggle, D. J., 1984, Subcellular distribution of [3H]nitrendipine binding in smooth muscle, J. Biol. Chem 259:2223–2226.
Miller, W. C., and Moore, J. B., 1984, High affinity binding sites for [3H]nitrendipine in rabbit uterine smooth muscle, Life Sci 34:1717–1724.
Golichowski, A. M., and Tzeng, D. Y., 1985, Binding of the calcium antagonist (3H)nitrendipine to human myometrial plasmalemma, Biol. Reprod 33:1105–1112.
Triggle, D. J., and Janis, R. A., 1987, Calcium channel ligands, Annu. Rev. Pharmacol. Toxicol 27:347–369.
Janis, R. A., and Triggle, D. J., 1984, 1,4-Dihydropyridine Ca2+ channel activators: A comparison of binding characteristics with pharmacology, Drug Dev. Res 4:257–274
Triggle, D. J., and Janis, R. A., 1984, Calcium channel antagonists: New perspectives from radioligand binding assay, in: Modern Methods in Pharmacology( N. Back and S. Spector, eds.) Alan R. Liss, New York, pp. 1–28.
Glossman, H., Ferry, D. R., Goll, A., Striessnig, J., and Zernig, G., 1985, Calcium channels and calcium channel drugs: Recent biochemical and biophysical findings, Arzneim. Forsch 35:1917– 1935.
Hess, P., Lansman, J. B., and Tsien, R. W., 1984, Different modes of Ca channels gating behavior favored by dihydropyridine Ca agonists and antagonists, Nature 311:599–635.
Murphy, K. M. M., Gould, R. J., Largent, B. L., and Snyder, S. H., 1983, A unitary mechanism of calcium antagonist drug action, Proc. Natl. Acad. Sci. U.S.A 80:860–864.
Pang, D. C., and Sperelakis, N., 1983, Nifedipine, diltiazem, beperidil and verapamil uptakes into cardiac and smooth muscles, Eur. J. Pharmacol 87:199–207.
Metzger, H., Stern, H. O., Pfilzer, G., and Reugg, J. C., 1982, Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle, Drug Res 32:1452–1457.
Epstein, P. M., Fiss, K., Hachisu, R., and Andrenyak, D. M., 1982, Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin, Biochem. Biophys. Res. Commun 105:1142–1146.
Sakamoto, H., and Huszar, G., 1986, Pharmacologic levels of nitrendipine do not affect actin-myosin interaction in the human uterus and placenta, Am. J. Obstet. Gynecol 154:402–407.
Huszar, G., and Bailey, B., 1979, Relationship between actin-myosin interaction and myosin light-chain phosphorylation in human placental smooth muscle, Am. J. Obstet. Gynecol 135:718– 726.
Csapo, A. I., 1959, Studies on excitation-contraction coupling, Ann. N.Y. Acad. Sci 81:453– 467.
Movsesian, M. A., Swain, A. L., and Adelstein, R. S., 1984, Inhibition of turkey gizzard myosin light chain kinase activity by dihydropyridine calcium antagonists, Biochem. Pharmacol 33:3759–3764.
Maigaard, S., Forman, A., and Andersson, K.-E., 1986, Inhibitory effects of nitrendipine on myometrial and vascular smooth muscle in human pregnant uterus and placenta, Acta Pharmacol. Toxicol 59:1–10.
Anderson, C. A., Scriabine, A., Maurer, S. C., and Janis, R. A., 1983, Effects of nitrendipine on rat uterine smooth muscle: Inhibition of contraction and ligand binding studies, Fed. Proc 42:367.
Hollingsworth, M., Edwards, D., and Donnai, P., 1987, Inhibition of contractions of the isolated pregnant human myometrium by calcium entry blockers, Med. Sci. Res 15:15–16.
Fleckenstein, A., 1981, Fundamental actions of calcium antagonists on myocardial and cardiac pacemaker cell membranes, in: New Perspectives on Calcium Antagonists( G. B. Weiss, ed.), Williams & Wilkins, Baltimore, pp. 59–81.
Hermann, P., and Morselli, P. L., 1985, Pharmacokinetics of diltiazem and other calcium entry blockers, Acta Pharmacol. Toxicol 57:10–20.
Reiter, M. J., Shand, D. G., and Pritchett, L. C., 1982, Comparison of intravenous and oral verapamil dosing Clin. Pharmacol. Ther 32:711–720.
Eichelbaum, M., Somogyi, A., von Unruh, G. E., and Dengler, H. J., 1981, Simultaneous determination of the intravenous and oral pharmakokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil, Eur. J. Clin. Pharmacol 19:133–137.
Mcallister, R. G., Jr., 1982, Clinical pharmakokinetics of calcium channel antagonists, J. Cardiovasc. Pharmacol 4(Suppl. 3): S340–S345.
Ochs, H. R., and Knuchel, M., 1984, Pharmacokinetics and absolute bioavailability of diltiazem in humans, Klin. Wochenschr 62:303–306.
Raemsch, K. D. and Sommer, J., 1983, Pharmacokinetics and metabolism of nifedipine, Hypertension 5(Suppl. II): 18–24.
Foster, T. S., Hamann, S. R., Richards, V. R., Bryant, P. J., Graves, D. A., and McAllister, R. G., 1983, Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects, J. Clin. Pharmacol 23:161–170.
Schlossman, K., Mendenwald, H., and Rosenkranz, H., 1975, Investigation on the metabolism and protein binding of nifedipine, in: 2nd International Adalat Symposium. New Therapy in Ischemic Heart Disease( W. Lochner, W. Braasch, and G. Kronenberg, eds.), Springer-Verlag, Berlin, pp. 33–39.
Yong, C. L., Kunka, R. L., and Bates, T. R., 1980, Factors affecting the plasma protein binding of verapamil and norverapamil in man, Res. Commun. Chem. Pathol. Pharmacol 30:329–339.
Keefe, D. L., Yee, Y. G., and Kates, R. E., 1981, Verapamil protein binding in patients and in normal subjects, Clin. Pharmacol. Ther 29:21–26.
Bloedow, D. C., Piepho, R. W., Nies, A. S., and Gal, J. 1982, Serum binding of diltiazem in humans, J. Clin. Pharmacol 22:201–205.
Hof, R. P., 1983, Calcium antagonist and the peripheral circulation: Differences and similarities between PY 108–068, nicardipine, verapamil and diltiazem, Br. J. Pharmacol 78:375–394.
Andersson, K. E., 1986, Pharmacodynamic profiles of different calcium channel blockers, Acta Pharmacol. Toxicol 58(Suppl. 2): 31–42.
Andersson, K. E., Ingemarsson, I., Ulmsten, U., and Wingerup, L., 1979, Inhibition of prostaglandin-induced uterine activity by nifedipine, Br. J. Obstet. Gynaecol 86:175–179.
Csapo, A. I., Puri, C. P., Tarro, S., and Henzl, M. R., 1982, Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine, Am. J. Obstet. Gynecol 142:483–491.
Forman, A., 1979, Calcium entry blockade as a therapeutic principle in the female urogenital tract, Acta Obstet. Gynecol. Scand. [Suppl.] 121:1–26.
U.S. Department of Health and Human Services, Public Health Service, 1986, Vital Statistics of the United States, 1982, Vol. 1 (Natality), National Center for Health Statistics, Hyattsville, MD.
Lindblom, B., Hamberger, L., and Wiqvist, N., 1978, Differentiated contractile effects of prostaglandins E and F on the isolated circular and longitudinal smooth muscle of the human oviduct, Fertil. Steril 30:553–559.
Lindblom, B., Hamberger, L., and Ljung, B., 1979, contractile patterns of isolated oviductal smooth muscle under different hormonal conditions, Fertil. Steril 33:283–287
Forman, A., Andersson, K.-E., and Ulmsten, U., 1983, Effects of calcium and nifedipine on noradrenaline- and PGF2α-induced activity of the ampullary-isthmic junction of the human oviduct in vitro, J. Reprod. Ferti 67:343–349.
Forman, A., Andersson, K. E., and Maigaard, S., 1986, Effects of calcium channel blockers on the female genital tract, Acta Pharmacol. Toxicol 58(Suppl. 2): 183–192.
von Euler, U. S., 1938, The action of adrenaline, acetylcholine and other substances on nerve-free vessels (human placenta), J. Physiol. (Lond.) 93:129–143.
Kitson, G. E., and Broughton Pipkin, F., 1981, Effects and interactions of prostaglandins E1 and E2 on human chorionic plate arteries, Am. J. Obstet. Gynecol 140:683–688.
Reilly, F. D., and Russel, P. P., 1977, Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta, Anat. Rec 188:277–286.
Maigaard, S., Forman, A., and Andersson, K.-E., 1984, Effects of nicardipine on human placental arteries, Gynecol. Obstet. Invest 18:217–224.
Maigaard, S., Forman, A., and Andersson, K.-E., 1986, Inhibitory effects of nitrendipine on myometrial and vascular smooth muscle in human pregnant uterus and placenta, Acta Pharmacol. Toxicol 59:1–10.
Broughton Pipkin, F., and Chinnery, E., 1985, The effects of calcium antagonist, nitrendipine, on responses of isolated strips of human chorionic plate artery to prostaglandin E2 and E1, Br. J. Pharmacol 86:705–709.
Reiner, O., and Marshall, J. M., 1976, Action of PGF2α on the uterus of the rat, Arch. Pharmacol 292:243–250.
Csapo, A. I., 1959, Studies on excitation-contraction coupling, Ann. N.Y. Acad. Sci 81:453–467.
Rubanyi, G., and Csapo, A. I., 1976, The “activator-Ca” of the pregnant and postpartum uterus, Life Sci 19:1239–1252.
Rubanyi, G., and Csapo, A. I., 1977, The effect of Ca-transport inhibitors on the excitability of the pregnant and post partum rabbit uterus, Life Sci 20:289–300.
Fleckenstein, A., 1977, Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle, Annu. Rev. Pharmacol. Toxicol 17:149–166.
Granger, S. E., Hollingsworth, M., and Weston, A. H., 1985, A comparison of several calcium antagonists on uterine, vascular and cardiac muscles from the rat, Br. J. Pharmacol 85:255–262.
Granger, S. E., Hollingsworth, M., Weston, A. H., 1986, Effects of calcium entry blockers on tension development and calcium influx in rat uterus, Br. J. Pharmacol 87:147–156.
Hollingsworth, M., Edwards, D., and Donnai, P., 1987, Inhibition of contractions of the isolated pregnant human myometrium by calcium entry blockers, Med. Sci. Res 15:15–16.
Hendricks, C. H., 1964, A new technique for the study of motility of the non-pregnant human uterus, J. Obstet. Gynaecol. Br. Commonw 71:712–715.
Moawad, A. H., and Bengtsson, L. P., 1967, In vivo studies of the motility patterns of the nonpregnant human uterus I: The normal menstrual cycle, Am J. Obstet. Gynecol 98:1052–1064.
Akerlund, M., and Andersson, K.-E., 1976, Effects of terbutaline on human myometrial activity and endometrial blood flow, Obstet. Gynecol 47:529–535.
Ylikorkala, O., and Dawood, M. Y., 1978, New concepts in dysmenorrhea, Am. J. Obstet. Gynecol 130:833–847.
Akerlund, M., 1979, Pathophysiology of dysmenorrhea, Acta Obstet. Gynecol. Scand 87:21–32.
Maigaard, S., Forman, A., and Andersson, K.-E., 1985, Differences in contractile activation between human nonpregnant myometrium and intramyometrial vessels, Acta Physiol. Scand 124:371–379.
Maigaard, S., Forman, A., and Andersson, K.-E., 1985, Different responses to prostaglandin F2α and E2 in human nonpregnant extra- and intramyometrial arteries, Prostaglandins 30:599–607.
Fuchs, A.-R., Coutinho, E. M., Xavier, R., Bates, P. E., and Fuchs, F., 1968, Effects of ethanol on the activity of the nonpregnant uterus and its reactivity to neurohypophyseal hormones, Am. J. Obstet. Gynecol 101:997–1000.
Akerlund, M., Stromberg, P., Forsling, M. L., Melin, P., and Vilhardt, H., 1983, Inhibition of vasopressin effects on the uterus by a synthetic analogue, Obstet. Gynecol 62:309–312.
Ulmsten, U., Andersson, K.-E., and Forman, A., 1978, Relaxing effects of nifedipine on the non¬pregnant human uterus in vitroand in vivo, Obstet. Gynecol 52:436–441.
Andersson, K.-E., and Ulmsten, U., 1978, Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhea, Br. J. Obstet. Gynaecol 85:142–148.
Sandahl, B., Ulmsten, U., and Andersson, K.-E., 1979, Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhea, Arch. Gynecol 227:147–151.
Mondero, N. A., 1983, Nifedipine in the treatment of dysmenorrhea, J. Am. Osteopath. Assoc 82:704–708.
Forman, A., Gandrup, P., Andersson, K.-E., and Ulmsten, U., 1982, Effects of nifedipine on spontaneous and methylergometrine-induced uterine activity post-partum, Am. J. Obstet. Gynecol 144:442–448.
Ulmsten, U., and Andersson, K.-E., 1979, Multichannel intrauterine pressure recording by means of microtransducers, Acta Obstet. Gynecol. Scand 58:115–120.
Forman, A., Gandrup, P., Andersson, K. E., and Ulmsten, U., 1982, Effects of nifedipine on oxytocin- and prostaglandin F2α-induced activity in the postpartum uterus. Am. J. Obstet. Gynecol 144:665–669.
Abel, M. H., and Hollingsworth, M., 1985, The potencies and selectivities of four calcium antagonists as inhibitors of uterine contractions in the rat in vivo, Br. J. Pharmacol 85:263–269.
Narimatsu, A., and Taira, N., 1976, Effects on atrioventricular conduction of calcium-antagonistic coronary vasodilators, local anesthetics and quinidine injected into the posterior and anterior septal artery of the atrioventricular node preparation of the dog, Naunyn Schmiedebergs Arch. Pharmacol 294:169–177.
Spedding, M., 1982, Differences between the effects of calcium antagonists in the pithed rat preparation, J. Cardiovasc. Pharmacol 4:973–979.
Hahn, D. W., McGuire, J. L., Vanderhoof, M., Ericson, E., and Pasquale, S. A., 1984, Evaluation of drugs for arrest of premature labor in a new animal model, Am. J. Obstet. Gynecol 148:775–778.
Lirette, M., Holbrook, H., and Katz, M., 1985, Effect of nicardipine HCl on prematurely induced uterine activity in the pregnant rabbit, Obstet. Gynecol 65:31–36.
Siimes, A. S. I., and Creasy, R. K., 1979, Cardiac and uterine hemodynamic responses to ritodrine hydrochloride administration in pregnant sheep, Am. J. Obstet. Gynecol 133:20–28.
Bieniarz, J., Ivankovich, A., and Scommenga, A., 1974, Cardiac output during ritodrine treatment on premature labor, Am. J. Obstet. Gynecol 118:910–920.
Katz, M., Robertson, P. A., and Creasy, R. K., 1981, Cardiovascular complications associated with terbutaline treatment for preterm labor, Am. J. Obstet. Gynecol 139:605–608.
Golichowski, A. M., Hathaway, D. R., Fineberg, N., and Peleg, D., 1985, Tocolytic and hemodynamic effects of nifedipine in the ewe, Am. J. Obstet. Gynecol 151:1134–1140.
Harake, B., Gilbert, R. D., Ashwal, S., and Power, G., 1987, Nifedipine: Effects on fetal and maternal hemodynamics in pregnant sheep, Am. J. Obstet. Gynecol 157:1003–1008.
Ducsay, C. A., Thompson, J. S., Wu, A. T., and Novy, M. J., 1987, Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: Fetal plasma concentrations and cardiorespiratory changes, Am. J. Obstet. Gynecol 157:1482–1486.
Veille, J. C., Bissonnette, J. M., and Hohimer, R. J., 1986, The effect of a calcium channel blocker (nifedipine) on uterine blood flow in the pregnant goat, Am. J. Obstet. Gynecol 154:1160–1163.
Parisi, V. M., Salinas, J. K., and Stockman, E. J., 1989, Placental vascular responses to nicardipine in the hypertensive ewe, Am. J. Obstet. Gynecol 161:1039–1043.
Ducsay, C. A., Cook, M. J., and Novy, M. J., 1985, Cardiorespiratory effects of calcium channel- blocker tocolysis in pregnant rhesus monkeys, in: The Physiological Development of the Fetus and Newborn( C. T. Jones and P. W. Nathanielsz, eds.), Academic Press, London, pp. 423–428.
Ducsay, C. A., McNutt, C. M., Harvey, L. M., and Gilbert, R. D., 1989, Effects of nicardipine on uteroplacental blood flow in the rhesus macaque, in: Proceedings of the Thirty-Sixth Annual Meeting of the Society for Gynecological Investigation, San Diego, p. 147
Forman, A., Andersson, K. E., and Ulmsten, U., 1981, Inhibition of myometrial activity by calcium antagonists, Semin. Perinatol 5:288–294.
Ulmsten, U., 1984, Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist, Arch. Gynecol 236:69–72.
Kaul, A. F., Osathanondh, R., Safon, L. E., Frigoletto, F. D., and Friedman, P. A., 1985, The management of preterm labor with the calcium channel-blocking agent nifedipine combined with the P-mimetic terbutaline, Drug Intell. Clin. Pharm 19:369–371.
Read, M. D., and Welby, D. E., 1986, The use of a calcium antagonist (nifedipine) to suppress preterm labour, Br. J. Obstet. Gynaecol 93:933–937.
Mari, G., Moise, K. J., Kirshon, B., Lee, W., and Cotton, D. B., 1989, Doppler assessment of the fetal and uteroplacental circulation after nifedipine therapy for preterm labor, in: Proceedings of the Thirty-Sixth Annual Meeting of the Society for Gynecologic Investigation, p. 284
Godfraind, T., 1983, Action of nifedipine on calcium fluxes and contraction in isolated rat arteries, J. Pharmacol. Exp. Ther 224:443–450.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Ducsay, C.A. (1990). Calcium Channels. In: Carsten, M.E., Miller, J.D. (eds) Uterine Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0575-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0575-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7873-3
Online ISBN: 978-1-4613-0575-0
eBook Packages: Springer Book Archive